Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity

Journal of Lipid Research

Volumn 40, Issue 5, 1999, Pages 948-954

  Bielicki, John K ^a   Forte, Trudy M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherogenesis; High density lipoproteins; Lecithin:cholesterol acyltransferase; Minimally oxidized LDL; Phospholipid hydroperoxides

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ENZYME ACTIVITY; HUMAN; LIPID OXIDATION; LIPOPROTEIN METABOLISM; PLASMA; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; BINDING SITES; CYSTEINE; DITHIONITROBENZOIC ACID; ENZYME INHIBITORS; HUMANS; LIPID PEROXIDES; LIPOPROTEINS, LDL; LIPOXYGENASE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 0032920929     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
2. Jonas, A. 1991. Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim. Biophys. Acta. 1084: 205-220.
3. Forte, T. M., J. K. Bielicki, R. Goth-Goldstein, J. Selmek, and M. R. McCall. 1995. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J. Lipid Res. 36: 148-157.
4. Glomset, J. A., G. Assmann, E. Gjone, and K. R. Norum. 1995. Familial lecithin:cholesterol acyltransferase deficiency. In The Metabolic Basis of Inherited Diseases. C. R. Scrivel, A. L. Beuaudent, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1933-1952.
5. Kuivenhoven, J. A., A. F. H. Stalenhoef, J. S. Hill, P. N. M. Demaker, A. Errami, J. J. P. Kastelein, and P. H. Pritchard. 1996. Two novel molecular defects in the LCAT gene are associated with fish eye disease. Arterioscler. Thromb. Vasc. Biol. 16: 294-303.
6. Ohta, T., R. Nakamura, Y. Ikeda, M. Shinohara, A. Miyazaki, S. Horiuchi, and I. Matsuda. 1992. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin:cholesterol acyltransferase. Biochim. Biophys. Acta. 1165: 119-128.
7. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
8. Bielicki, J. K., T. M. Forte, and M. R. McCall. 1996. Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity. J. Lipid Res. 37: 1012-1021.
9. Avogaro, P., G. B. Bon, and G. Cazzolato. 1988. Presence of a modified low density lipoprotein in humans. Arteriosclerosis. 8: 79-87.
10. Palinski, W., M. E. Rosenfeld, S. Ylä-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. 86: 1372-1376.
11. Ylä-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
12. Sevanian, A., J. Hwang, H. Hodis, G. Cazzolato, P. Avogaro, and G. Bittolo-Bon. 1996. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Arteriosder. Thromb. Vasc. Biol. 16: 784-793.
13. Hodis, H. N., D. M. Kramsch, P. Avogaro, G. Bittolo-Bon, G. Cazzolato, J. Hwang, H. Peterson, and A. Sevanian. 1994. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein. J. Lipid Res. 35: 669-677.
14. - is a lipid hydroperoxide-enriched circulating lipoprotein. J. Lipid Res. 38:419-428.
15. Quinn, M. T., S. Parathasarathy, L. G. Loren, and D. Steinberg. 1987. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84: 2995-2998.
16. Berliner, J. A., M. C. Territo, A. Sevanian, S. Ramin, J. Ai Kim, B. Bamshad, M. Esterson, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266.
17. Cushing, S. D., J. A. Berliner, A.J. Valente, M. C. Territo, M. Navab, F. Parhami, R. Gerrity, C. J. Schwartz, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. 87: 5134-5138.
18. Rajavashisth, T. B., A. Andalibi, M. C. Territo, J. A. Berliner, M. Navab, A. M. Fogelman, and A. J. Lusis. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 344: 254-257.
19. Parthasarathy, S., J. Barnett, and L. G. Fong. 1990. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1044: 265-283.
20. Watson, A. D., J. A. Berliner, S. Y. Hama, B. N. La Du, K. F. Faull, A. M. Fogelman, and M. Navab. 1995. Protective effect of high density lipoprotein associated paraoxonase. J. Clin. Invest. 96: 2882-2891.
21. Aviram, M., M. Rosenblat, C. L. Bisgaier, R. S. Newton, S. L. Primo-Parmo, and B. N. La Du. 1998. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. J. Clin. Invest. 101: 1581-1590.
22. Lindgren, F. T., L. C. Jensen, and F. T. Hatch. 1972. The isolation and quantitative anaylsis of serum lipoproteins. In Blood Lipids and Lipoproteins: Quantitation, Composition, and Metabolism. G. J. Nelson, editor. Wiley-Interscience, New York. 181-274.
23. Kosugi, H., T. Kojima, and K. Kikugawa. 1991. Characteristics of the thiobarbituric acid reactivity of oxidized fats and oils. J. Am. Oil Chem. Soc. 68: 51-55.
24. El-Saadani, M., H. Esterbauer, M. El-Sayed, M. Goher, A. Y. Nassar, and G. Jurgens. 1989. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30: 627-630.
25. Sparrow, C. P., S. Parthasarathy, and D. Steinberg. 1988. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J. Lipid Res. 29: 745-753.
26. Nagata, Y., Y. Yamamoto, and E. Nike. 1996. Reaction of phosphatidylcholine hydroperoxide in human plasma: the role of peroxidase and lecithin:cholesterol acyltransferase. Arch. Biochem. Biophys. 329: 24-30.
27. Zhang, L., M. Maiorino, A. Roveri, and F. Ursini. 1989. Phospholipid hydroperoxide glutathione peroxidase: specific activity in tissues of rats of different age and comparison with other glutathione peroxidases. Biochim. Biophys. Acta. 1006: 140-143.
28. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 912-917.
29. Chen, C. H, and J. J. Albers. 1982. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase. J.. Lipid Res. 23: 680-691.
30. Markwell, M. A., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
31. Chen, P. S., T. Y. Torihara, and H. Warner. 1956. Microdetermination of phosphorus. Anal. Chem. 28: 1757-1759.
32. Sale, F. O., S. Marchesini, P. H. Fishman, and B. Berra. 1984. A sensitive enzymatic assay for determination of cholesterol in lipid extracts. Anal. Biochem. 142: 347-350.
33. Francone, O. L., and C. J. Fielding. 1991. Effects of site directed mutagenesis at residues cysteine-31 and cysteine-184 on lecithin-cholesterol acyltransferase activity. Proc. Natl. Acad. Sci. USA. 88: 1716-1720.
34. Bowry, V. W., K. K. Stanley, and R. Stocker. 1992. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. USA. 89: 10316-10320.
35. Christison, J. K., K. Rye, and R. Stocker. 1995. Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein. J. Lipid Res. 36: 2017-2026.
36. McCall, M. R., J. Y. Tang, J. K. Bielicki, and T. M. Forte. 1995. Inhibition of lecithin:cholesterol acyltransferase and modification of HDL apolipoproteins by aldehydes. Arterioscler. Thromb. Vasc. Biol. 15: 1599-1606.
37. Folcik, V. A., R. A. Nivar-Aristy, L. P. Krajewski, and M. K. Cathcart. 1995. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96: 504-510.
38. Williams, K. J., and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15; 551-560.
39. Parthasarathy, S., and D. Steinberg. 1992: Cell-induced oxidation of LDL. Curr. Opin. Lipidol. 3: 313-317.